40.24
+0.87(+2.21%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2455
First IPO Date
November 10, 2017
| Name | Title | Pay | Year Born |
| Dr. Minmin Yang Ph.D. | Co-Founder, Chairman & Chief Executive Officer | 0 | 1972 |
| Ms. Wu Yifei | Secretary, Chief Financial Officer & Accounting Supervisor | 0 | 1979 |
| Dr. Shuhai Zhao Ph.D. | Co-founder & Chief Scientific Officer | 0 | 1963 |
| Dr. David Chen Ph.D. | Executive Vice President, Chief Operation Officer & Head of CDMO | 0 | N/A |
| Dr. Dezhi Sha Ph.D. | Senior Vice President of Process Technology & Manufacturing | 0 | N/A |
| Dr. Shijie Zhang Ph.D. | Chief Technology Officer | 0 | 1964 |
| Dr. Jing Li Ph.D. | Senior Vice President of Process Chemistry & President of PharmaBlock (USA), Inc. | 0 | 1973 |
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.